future direction for anti-amyloid immunotherapies
Published 1 year ago • 68 plays • Length 5:40Download video MP4
Download video MP3
Similar videos
-
2:07
future of tau-targeting immunotherapies in alzheimer’s disease
-
1:55
next-generation anti-amyloid therapies: prioritizing selectivity
-
5:48
meta-analysis of the latest anti-amyloid immunotherapies: benefit vs risk
-
1:46
next steps in anti-amyloid immunotherapy
-
2:38
development of a new anti-amyloid antibody pmn310 for the treatment of alzheimer’s disease
-
1:13
is amyloid load a valid surrogate endpoint for ad clinical trials?
-
1:12
alz-801 in combination with anti-amyloid antibodies for the treatment of alzheimer’s disease
-
2:26
why have anti-amyloid monoclonal antibodies performed differently in phase iii trials
-
2:33
anti-amyloid therapy for alzheimer's disease: beyond the 18-month mark
-
10:28
emerging treatments for early alzheimer’s disease: mechanisms of action
-
3:49
updates on anti-amyloid monoclonal antibodies for ad in phase iii trials
-
3:41
finding the 'goldilocks' zone for alzheimer’s disease immunotherapies
-
2:04
anti-amyloid combination strategies in alzheimer's disease
-
2:47
ad/pd™️ 2024 – highlights research on earlier treatment with anti-amyloid immunotherapies
-
2:02
future directions for neuroimaging in pd: neuroinflammation
-
1:14
potential of anti-amyloid drugs for treating alzheimer's disease
-
1:28
second generation of anti-amyloid monoclonal antibodies for alzheimer's disease
-
4:55
enhancing trials to prove disease modification in early alzheimer's disease
-
1:37
immunotherapy for alzheimer’s disease shows promise